Global In Vitro Fertilization Service Market Growth (Status and Outlook) 2025-2031

The global In Vitro Fertilization Service market size is predicted to grow from US$ 4227 million in 2025 to US$ 10890 million in 2031; it is expected to grow at a CAGR of 17.1% from 2025 to 2031.

In Vitro Fertilization（IVF) service refers to the process of combining an egg with sperm in a laboratory to form a fertilized egg, which is then transferred to the female uterus to develop into an embryo, ultimately achieving pregnancy and childbirth. IVF is suitable for various infertility situations, including blocked fallopian tubes, unexplained infertility, positive anti sperm antibodies, immunological infertility, asthenozoospermia, endometriosis with pelvic adhesions or fallopian tube abnormalities.

United States market for In Vitro Fertilization Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for In Vitro Fertilization Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for In Vitro Fertilization Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key In Vitro Fertilization Service players cover Fosun Medical Group, Chengdu Huanuo Medical Health Technology, Anhui Bocheng Medical, Fengxi International Medical, Shenzhen Aiwei Aifu Hospital Management Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “In Vitro Fertilization Service Industry Forecast” looks at past sales and reviews total world In Vitro Fertilization Service sales in 2024, providing a comprehensive analysis by region and market sector of projected In Vitro Fertilization Service sales for 2025 through 2031. With In Vitro Fertilization Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro Fertilization Service industry.

This Insight Report provides a comprehensive analysis of the global In Vitro Fertilization Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In Vitro Fertilization Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vitro Fertilization Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro Fertilization Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro Fertilization Service.

This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Fertilization Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
In Vitro Fertilization And Embryo Transfer
Intracytoplasmic Sperm Injection
Preimplantation Genetic Diagnosis
Germinal Vesicle Transfer

Segmentation by Application:
Severe Tubal Disease
Endometriosis
Immunological Infertility
Male Infertility
Unexplained Infertility
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Fosun Medical Group
Chengdu Huanuo Medical Health Technology
Anhui Bocheng Medical
Fengxi International Medical
Shenzhen Aiwei Aifu Hospital Management Group
Kuanzhai Medical International IVF
Beijing Jinxin International Medical Technology
Wuhan Ruibeixin Medical Technology
Guangzhou Xiyuan Fertility
Taiorient
Boston IVF
Irvine Scientific
IVFtech ApS
CARE Fertility
HRC Fertility
GenPrime
ACRC Fertility Holding Group
Miwahealth
New Hope Fertility Center
AmCan Fertility Group

Please note: The report will take approximately 2 business days to prepare and deliver.